"Today, clinical post-registration studies continue, more than 3.5 thousand patients received the vaccine," RIA Novosti Murashko quotes.
He said that "everything is going as usual."
He also noted that two more Russian vaccines are undergoing clinical trials - these are vaccines from the Chumakov Institute and the Vector Center.
Earlier it became known that the first batch of the Sputnik V coronavirus vaccine entered the civil circulation in Moscow.
In August, the Gamaleya Center spoke about plans to study secondary immunity to the disease after vaccination.
It was reported that the mass vaccination against COVID-19, which will be voluntary, will start after November-December.